Ronald W. Davis, PhD's presentation at the IIMEC13

I don't understand the fears over the possibility that the nanoneedle test might not be specific to ME/CFS.

Even if it's not, I think it would be the biggest advance ever seen in this field, stimulate a lot of interest and increase the perception that this is a real disease.

 

I want them to identify the molecule causing the result, it may lead to a disease mechanism if its traced back to where its created.

 

It might even work in our favour if the same abnormality is shown in a 'real' disease like MS or lupus. Harder to deny that way. If a novel, unfamiliar test shows an abnormality only in ME/CFS, the BPS crowd will still be able to play god of the gaps strategy and say it's caused by spending too much time in bed, the test shows nothing of clinical relevance, or whatever.